| Structure | Chemical Name | CAS | MF |
|
Eslicarbazepine
|
|
|
|
Eslicarbazepine Glucuronide SodiuM Salt
|
|
C21H21N2NaO8
|
|
ETBICYTHIONAT
|
|
C6H11O3PS
|
|
ETBICYPHAT
|
1005-93-2
|
C6H11O4P
|
|
ETBICYTHIONAT
|
224790-71-0
|
C6H11O3PS
|
|
Etarotene
|
87719-32-2
|
C25H32O2S
|
|
|
4ET-BHT-OOH
|
|
|
|
|
ETBINYLESTRADIOL
|
|
|
|
Etasuline
|
16781-39-8
|
C16H15ClN2S
|
|
|
ESKUGEL GP AC 7F
|
|
|
|
Etatryn
|
3440-19-5
|
C5H6Cl2N4
|
|
etazepine
|
88124-27-0
|
C17H17NO2
|
|
(1E,3S)-5-Methyl-1-(phenylsulphonyl)hex-1-en-3-amine hydrochloride
|
|
C13H20ClNO2S
|
|
(2E,4S)-2-Methyl-4-[(1H-purin-6-yl)amino]-2-penten-1-ol
|
|
C11H15N5O
|
|
(13E,15S)-9-(Methoxyimino)-15-[(trimethylsilyl)oxy]-10,13-prostadien-1-oic acid methyl ester
|
55821-11-9
|
C25H45NO4Si
|
|
(5E,10S)-4-(Methoxymethoxy)-10-(tributylstannyl)-5,10,11-tridecatrienal
|
|
C27H50O3Sn
|
|
[E,S,(-)]-12-Methoxy-9-octadecenoic acid methyl ester
|
|
C20H38O3
|
|
[(E)-1-[(S)-1-Methylneopentyl]-1-butenyl]p-tolyl sulfoxide
|
|
C34H50OS
|
|
4-{(E)-3-[(2S)-1-methyltetrahydro-1H-pyrrol-2-yl]-2-propenyl}morpholine
|
|
C12H22N2O
|
|
(5E,6S)-4β-(2-Methoxy-2-oxoethyl)-5-(2-hydroxyethylidene)-6α-(β-D-glucopyranosyloxy)-5,6-dihydro-4H-pyran-3-carboxylic acid methyl ester
|
91679-27-5
|
C18H26O12
|
|
|
[(E)-1-[(S)-α-Methylpentyl]-1-butenyl]p-tolyl sulfoxide
|
|
|
|
(6E,10S)-8-(Methoxymethoxy)-10-(tributylstannyl)-6,10,11-tridecatrienal
|
|
C27H50O3Sn
|
|
(13E,15S)-1-[2-(Methoxycarbonyl)ethyl]-15-hydroxy-16-(pentafluorophenoxy)-17,18,19,20-tetranorprost-13-en-9-one
|
|
C26H33F5O5
|
|
(-)-[(E,S)-1-Methyl-2-butenyl]phenyl ether
|
|
C22H26O
|
|
(1E,3S)-3-Methyl-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,4-pentadien-3-ol
|
|
C15H24O
|
|
(E,S)-4-[(1-Methoxy-1-methylethyl)peroxy]-2-nonen-1-one
|
|
C13H24O4
|
|
(13E,15S)-1-[2-(Methoxycarbonyl)ethyl]-15-hydroxy-16-phenoxy-17,18,19,20-tetranorprost-13-en-9-one
|
|
C26H38O5
|
|
(13E,15S)-9-(Methoxyimino)-15-[(trimethylsilyl)oxy]-8(12),13-prostadien-1-oic acid methyl ester
|
53044-56-7
|
C25H45NO4Si
|
|
ETAZOLATE
|
51022-77-6
|
C14H19N5O2
|
|
|
Etazolate, HCl
|
|
|
|
ETAZOLATE
|
35838-58-5
|
C14H18N5O2HCl
|
|
|
Erv25 protein
|
|
|
|
|
ERV2 protein
|
|
|
|
|
ERV1 protein
|
141933-92-8
|
|
|
|
Erv29 protein
|
|
|
|
|
ETCHANT, BUFFERED OXIDE
|
|
|
|
|
ETCHANT,BUFFEREDOXIDE,40:1,SURFACTANATED,ELECTRONIC/CLEANROOMGRADE
|
|
|
|
|
ETCHANT,BUFFEREDOXIDE,6:1,SURFACTANATED,ELECTRONIC/CLEANROOMGRADE
|
|
|
|
|
ETCHANT,BUFFEREDOXIDE,34:5,ELECTRONIC/CLEANROOMGRADE
|
|
|
|
|
ETCHANT,BUFFEREDOXIDE,4:1,ELECTRONIC/CLEANROOMGRADE
|
|
|
|
|
ETCHANT,BUFFEREDOXIDE,15:1,ELECTRONIC/CLEANROOMGRADE
|
|
|
|
|
Etching printing ink
|
|
|
|
|
ETCHING MIXTURE (500ML IN 1 LITRE BOTTLE)
|
|
|
|
|
Etch-It
|
|
|
|
|
ETCHING LIQUID
|
|
|
|
|
ETCHING INK
|
|
|
|
|
ET(B)R-LP-2 protein
|
|
|
|
|
Etch-N-Seal
|
|
|
|
|
Etch&Prime
|
|
|
|
|
80-59 Etch Resist Black Ink
|
|
|
|
|
ERWINIAMITSUENSISGUM
|
|
|
|
|
Es-200LSodiumSalt,DiamineWithSulfonicAcidFunctionalGroup
|
|
|
|
EsMolol-d7 Hydrochloride
|
|
C16H26ClNO4
|
|
EsMolol Acid-d7
|
|
C15H23NO4
|
|
EsMolol Acid SodiuM Salt
|
83356-60-9
|
C15H22NNaO4
|
|
Esmolol hydrochloride
|
81161-17-3
|
C16H26ClNO4
|
|
|
esmolol esterase
|
|
|
|
esmolol
|
84057-94-3
|
C16H25NO4
|
|
Esmolol
|
81147-92-4
|
C16H25NO4
|
|
|
ESMOLOL ACID
|
|
C15H23NO4
|
|
ESMOLOL
|
103598-03-4
|
C16H25NO4
|
|
Ethyl tetrahydrofurfuryl ether
|
62435-71-6
|
C7H14O2
|
|
|
(9α,11α,13E,15S)-6-Nitro-9,11,15-trihydroxyprost-13-en-1-oic acid
|
|
|
|
(11α,13E,17S)-9-O-Acetyl-17,20-dimethyl-15-oxo-2-(phenylseleno)-11-O-tetrahydropyranyl-prosta-13-en-1-oic Acid-d3 Methyl Ester (Mixture of Diastereomers)
|
|
C36H54O7Se
|
|
|
ETEC-binding inhibitory factor (BIF)
|
|
|
|
|
ERYBRAEDINC
|
|
|
|
|
Erychrozol
|
|
C34H52O13
|
|
ERYCHROSIDE
|
|
C4H8O4
|
|
erycibelline
|
107633-95-4
|
C7H13NO2
|
|
|
Erycibelline
2β,7β-Dihydroxynortropane
|
|
C7H13NO2
|
|
|
Erycibe alkaloid Ⅱ
|
|
C10H17NO3
|
|
|
ERYCIB ALKALOID II
|
|
|
|
|
EryCIII protein
|
|
|
|
|
EryBV protein
|
|
|
|
|
Erycordine
|
|
C35H54O14
|
|
(22E,24S)-27-Nor-5α-ergosta-7,22-dien-3β-ol
|
54848-29-2
|
C27H44O
|
|
(22E,24S)-27-Nor-5α-ergost-22-en-3β-ol
|
58514-32-2
|
C27H46O
|
|
|
ET-1(Cys(Acm)(1,15)-Ala(3)-Leu(7)-dAsp(8)-Aib(11))
|
|
|
|
|
Erx protein
|
|
|
|
ESP
|
2674-91-1
|
C7H17O4PS2
|
|
|
EspA protein
|
|
|
|
|
ESPARTOGRASS
|
|
|
|
|
ESPARTODUST
|
|
|
|
(1E,3R,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-phenoxymethyl-5H-cyclopent[e]oxacyclotridecin-5-one
|
62411-17-0
|
C22H28O5
|
|
(1E,3R,5Z)-3,11-Bis(tert-butyldimethylsilyloxy)-1-iodo-1,5-undecadiene
|
|
C23H47IO2Si2
|
|
Espatropate
|
132829-83-5
|
C19H23N3O3
|
|
ERYLKDQQLLGFWGC
|
|
C85H126N22O23S
|
|
ERYLKDQQLLGF
|
|
C69H108N18O20
|
|
EsoMeprazole-d3 SodiuM Salt
|
|
C17H18N3NaO3S
|
|
EsoMeprazole related substance H193/61
|
784143-42-6
|
C18H21N3O3S
|
|
EsoMeprazole related substance H431/41
|
1227380-90-6
|
C16H15N3O4
|
|
|
Esomefrrazole
|
|
|
|
eryloside F
|
269055-90-5
|
C41H66O12
|
|
|
EsomeprazolePellets(8.5%,22%)
|
|
|
|
|
EsomeprazolePowder&Pellets
|
|
|
|
|
EsomeprazoleOmeprazolePowder&Pellets
|
|
|
|
|
EsomerprazoleK
|
|
|
|
Esomeprazole potassium
|
161796-84-5
|
C17H20KN3O3S
|
|
|
ESOMEPRAZOLEMAGNESIUMTRIHYDRATE(SUBJECTTOPATENTFREE)
|
|
|
|
Esomeprazole magnesium trihydrate
|
217087-09-7
|
C34H38MgN6O7S2
|